Webinar
Ann Theodore Foundation Learning Opportunities in Medicine and Sarcoidosis, 2026–2027: Information Session
SHARE
The Ann Theodore Foundation (ATF), in partnership with Milken Institute Strategic Philanthropy’s Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting applications from independent researchers for the second cycle of one of its funding programs, ATF Learning Opportunities in Medicine and Sarcoidosis (LOMAS), through Monday, October 26, 2026.
Watch the informational session for potential applicants, which was held on Thursday, June 24, 2026.
ATF-LOMAS supports early-career investigators interested in studying the inflammatory disorder sarcoidosis. “Early-career” is defined as being within the first five years of an independent faculty appointment. Awardees will receive up to USD$200,000 over two years for research projects focused on the biology, epidemiology, or clinical care of sarcoidosis, and each awardee will be paired with a faculty mentor. Applicants are encouraged to submit optional letters of intent by Thursday, July 23, 2026.
Please see the full request for proposals for additional information.
SHARE
Related Content
-
From Misdiagnosis to Momentum: How Philanthropy Fast-Tracks Treatments for Rare Diseases
Imagine living with a disease so mysterious that few people have heard of it—yet it shapes every part of your daily life. For millions of people living with rare or poorly understood health conditions, their (often devastating) symptoms are...Read ArticleImage
Quinton Banks, PhD
Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyQuinton Banks,PhD, is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. His extensive scientific background includes research into chronic pain, taste perception, and muscle physiology. -
Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...Read Article -
Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...Read Article -
Ann Theodore Foundation Breakthrough Sarcoidosis Initiative Grant Awardees 2023
The Ann Theodore Foundation and the Milken Institute are pleased to announce the five research teams selected to receive funding for research to advance understanding of the underlying biology of sarcoidosis, a poorly understood immune...Read Article -
Sarcoidosis Case Study
Situation Sarcoidosis is defined by the dramatic accumulation of granulomas—dense clusters of immune cells—in organs throughout the body. Individuals living with sarcoidosis often go undiagnosed for years, enduring symptoms such as...Read Article -
Request for Proposals: Ann Theodore Foundation Learning Opportunities in Medicine and Sarcoidosis
Recognizing that support for early-career talent in the sarcoidosis research and clinical field is key to accelerating breakthroughs, the Ann Theodore Foundation is launching the next cycle of the Ann Theodore Foundation Learning...Read Article -
Anxiety: A Giving Smarter Guide
Anxiety is a natural and adaptive emotion that promotes vigilance against potential threats. However, anxiety that persists or is disproportionate to actual risk becomes dysfunctional and can impair daily functioning.Read ReportIM
